Literature DB >> 2850778

Neurovirulence of individual plaque stocks of Herpes simplex virus type 2 strain HG 52.

M Y Taha1, S M Brown, G B Clements.   

Abstract

The virulence of ten independent plaque stocks of HSV-2 strain HG 52 was determined by intracranial inoculation of 3 week old BALB/c mice. The ten stocks exhibited a range of LD50 which could be grouped into three classes; high (less than 10(3) pfu/mouse), intermediate (10(3)-10(4) pfu/mouse) and low (greater than 10(5) pfu/mouse). Analysis of the ten stocks using six different restriction endonucleases showed no significant variation in the size and distribution of fragments. Isolates from the brains of dead mice had restriction enzyme profiles indistinguishable from the initial infecting virus. The pfu:particle ratios of the virus stocks were comparable. There were no significant differences between the single growth cycle characteristics in vitro of the parental HG 52 and the various plaque purified stocks. In vivo after intracranial inoculation the low virulence stocks grew poorly while those of high virulence grew well. Plaques were picked from the high and low virulence stocks after passage five times in vitro and re-assayed for virulence. In some cases there were differences in the LD50s of passaged plaque isolates from that of parental stock. The restriction enzyme profiles of the passaged plaque isolates remained unchanged. The analysis has clearly demonstrated virulence heterogeneity within a single HSV-2 virus stock.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850778     DOI: 10.1007/bf01319805

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  23 in total

1.  Isolation and characterization of deletion mutants of herpes simplex virus type 2 (strain HG52).

Authors:  J Harland; S M Brown
Journal:  J Gen Virol       Date:  1985-06       Impact factor: 3.891

2.  Isolation, complementation and preliminary phenotypic characterization of temperature-sensitive mutants of herpes simplex virus type 2.

Authors:  J Esparza; D J Purifoy; P A Schaffer; M Benyesh-Melnick
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

3.  Comparative studies of type 1 and type 2 & 'herpes simplex' viruses.

Authors:  G Plummer; J L Waner; C P Bowling
Journal:  Br J Exp Pathol       Date:  1968-04

4.  Nucleotide sequences of the joint between the L and S segments of herpes simplex virus types 1 and 2.

Authors:  A J Davison; N M Wilkie
Journal:  J Gen Virol       Date:  1981-08       Impact factor: 3.891

5.  Replication at body temperature selects a neurovirulent herpes simplex virus type 2.

Authors:  R L Thompson; J G Stevens
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

6.  Three mutants of herpes simplex virus type 2: one lacking the genes US10, US11 and US12 and two in which Rs has been extended by 6 kb to 0.91 map units with loss of Us sequences between 0.94 and the Us/TRs junction.

Authors:  S M Brown; J Harland
Journal:  J Gen Virol       Date:  1987-01       Impact factor: 3.891

7.  Two avirulent herpes simplex viruses generate lethal recombinants in vivo.

Authors:  R T Javier; F Sedarati; J G Stevens
Journal:  Science       Date:  1986-11-07       Impact factor: 47.728

8.  Infections of susceptible and resistant mouse strains with herpes simplex virus type 1 and 2.

Authors:  L Caspary; B Schindling; S Dundarov; D Falke
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

9.  Experimental infection of inbred mice with herpes simplex virus. III. Comparison between newborn and adult C57BL/6 mice.

Authors:  R Zawatzky; H Engler; H Kirchner
Journal:  J Gen Virol       Date:  1982-05       Impact factor: 3.891

10.  Differences in neurovirulence among isolates of Herpes simplex virus types 1 and 2 in mice using four routes of infection.

Authors:  J T Richards; E R Kern; J C Overall; L A Glasgow
Journal:  J Infect Dis       Date:  1981-11       Impact factor: 5.226

View more
  4 in total

1.  Genomic sequences of a low passage herpes simplex virus 2 clinical isolate and its plaque-purified derivative strain.

Authors:  Robert Colgrove; Fernando Diaz; Ruchi Newman; Sakina Saif; Terry Shea; Sarah Young; Matt Henn; David M Knipe
Journal:  Virology       Date:  2013-12-31       Impact factor: 3.616

2.  Quantitative Evaluation of Protein Heterogeneity within Herpes Simplex Virus 1 Particles.

Authors:  Nabil El Bilali; Johanne Duron; Diane Gingras; Roger Lippé
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

3.  Molecular Evolution of Herpes Simplex Virus 2 Complete Genomes: Comparison between Primary and Recurrent Infections.

Authors:  Miguel A Minaya; Travis L Jensen; Johannes B Goll; Maria Korom; Sree H Datla; Robert B Belshe; Lynda A Morrison
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

4.  Colonization of adrenal glands and ovaries of mice by HSV-2 variants. I. Virological studies.

Authors:  J Podlech; K Weise; D Falke
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.